negativity – Page 4 – Communicable Diseases Research

Hypopharyngeal Ulcers in COVID-19: Histopathological and Virological Analyses – A Case Report

COVID-19의 하인두 궤양: 조직병리학적 및 바이러스학적 분석 – 사례 보고서

Case Reports

Published on 2021-07-052022-09-11
Journal: Frontiers in Immunology [Category] SARS, 바이오마커, 진단,

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

Ivermectin Covid-19 환자 (Ivercor-Covid19)의 입원을 예방하기위한 Ivermectin 무작위, 이중 맹검, 위약 대조 시험

Randomized Controlled Trial

Published on 2021-07-022022-08-13
Journal: BMC Infectious Diseases [Category] 임상, 치료제,

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus age Arm Chain Reaction changed conducted coronavirus coronavirus disease COVID-19 determine Disease progression dose double-blind Efficacy End points evaluated events groups had no high-risk population Hospitalization hospitalizations Inclusion individual individuals with COVID-19 invasive invasive mechanical invasive mechanical ventilatory support invasive MVS Ivermectin ivermectin group ivermectin treatment limitation measure median time negativity no significant differences no significant effect objective Odds ratio outcome outcomes Patient patient’s weight patients patients with COVID-19 Placebo placebo group placebo-controlled study placebo-controlled trial polymerase chain polymerase chain reaction positive nasal swab Prevent prevent disease progression Primary outcome Randomized randomized, double-blind, placebo-controlled study required respiratory Result SARS-CoV-2 SARS-CoV2 Scientific community secondary outcome Secondary outcomes severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significant difference significant differences significant effect statistically statistically significant difference study enrollment supplementary material symptom onset telephone the median time Treatment Trial Trial registration ventilatory support
[DOI] 10.1186/s12879-021-06348-5 PMC 바로가기 [Article Type] Randomized Controlled Trial

COVID-19 positivity associated with traumatic stress response to childbirth and no visitors and infant separation in the hospital

Article

Published on 2021-06-292022-10-29
Journal: Scientific Reports [Category] COVID-19, MERS, SARS,

Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19

경증 COVID-19의 상부 호흡기 증상을 감소시키는 Ivermectin Mucoadhesive Nanosuspension Nasal Spray의 임상, 생화학적 및 분자 평가

Randomized Controlled Trial

Published on 2021-06-152022-09-11
Journal: International journal of nanomedicine [Category] 임상, 치료제,

[키워드] age Anosmia anti-parasitic assessment assessments biochemical biochemical and molecular biochemical parameter Biochemical parameters Blood C-reactive protein clinical clinical trial Complete complete blood counts cough COVID-19 D-dimer diagnosed dimer Duration Dyspnea effective female Fever gastrointestinal symptoms hematological in vitro inhibit SARS-CoV-2 intranasal Ivermectin ivermectin nanosuspension male Manifestations Mild nasal Nasal spray nasal spray. Nasopharyngeal swab nasopharyngeal swabs Negative PCR negativity nucleic acid Patient performed Pharyngeal swab presenting protocol Randomly Replication respiratory rRT-PCR Safe SARS-CoV-2 replication Serum ferritin shown significant difference significantly shorter spray the patient therapeutic efficacy Treatment upper viral clearance was performed
[DOI] 10.2147/IJN.S313093 PMC 바로가기 [Article Type] Randomized Controlled Trial

Exploring the Relationships between Resilience and Turnover Intention in Chinese High School Teachers: Considering the Moderating Role of Job Burnout

Article

Published on 2021-06-132022-10-29
Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS,

Diagnosis of COVID-19 in children guided by lack of fever and exposure to SARS-CoV-2

Research

Published on 2021-06-112022-10-05
Journal: Pediatric Research [Category] COVID19(2023년), SARS, 임상, 진단,

How do you feel during the COVID-19 pandemic? A survey using psychological and linguistic self-report measures, and machine learning to investigate mental health, subjective experience, personality, and behaviour during the COVID-19 pandemic among university students

Research Article

Published on 2021-06-022022-10-28
Journal: BMC Psychology [Category] COVID-19, MERS, SARS,

[키워드] affecting Analysis Anxiety assessment Character computing consequence Corona virus country COVID-19 COVID-19 pandemic Culture cut off Depression description Descriptive analysis develop Emotion perception exploratory expressing Germany Health help investigated Linguistic analysis lockdown machine machine learning Measures men Mental mental health negativity pandemic Participants Personality physical predicted provide provided Psychological Psychological intervention psychologically questionnaire Questionnaires raised reported Result risk sample sizes Self-concept significantly subjects supplementary material Support Symptom Symptoms the mean traits variable WHO women Worry
[DOI] 10.1186/s40359-021-00574-x PMC 바로가기 [Article Type] Research Article

Positive Organisational Arts-Based Youth Scholarship: Redressing Discourse on Danger, Disquiet, and Distress during COVID-19

Article

Published on 2021-05-252022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy

정기적인 정맥 면역글로불린 요법을 받는 코로나바이러스 질병 2019 환자의 중등도 폐렴 예후에 대한 2상 안전성 및 효능 연구

Clinical Trial

Published on 2021-05-202022-09-11
Journal: The Journal of Infectious Diseases [Category] SARS, 임상, 진단, 치료제,

[키워드] 1:1 adjuvant adverse event adverse events antiviral drug antiviral drugs benefit body temperature both groups Chain Reaction conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients demonstrated died Diseases Duration Efficacy eligible patient evaluate except for group Hospital stay Immunoglobulin immunoglobulin therapy in both group Intravenous immunoglobulin IVIG mechanical ventilation median time Mild mild to moderate moderate multicenter negativity normalization not significantly different on mechanical ventilation Open-label oxygen oxygen saturation Patient percentage percentages phase Pneumonia polymerase chain polymerase chain reaction Randomized randomized study receive Regular Safe Safety SARS-CoV-2 significantly shorter Standard of care therapeutic benefits Treatment
[DOI] 10.1093/infdis/jiab098 PMC 바로가기 [Article Type] Clinical Trial

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus

SARS-CoV-2 코로나바이러스에 대한 항체 반응에 대한 치료 요법의 영향

Immunology

Published on 2021-04-152022-09-12
Journal: Frontiers in Immunology [Category] MERS, SARS, 진단,

[키워드] 95% CI absence affecting age analyzed Antibody Response Antibody test antimalarial drug asymptomatic patients Cancer cephalosporins chloroquine/hydroxychloroquine Clinical characteristics convalescent stage coronavirus disease correlated COVID-19 Critical Critically ill patient determine develop Dyspnea Evidence Factor Fever global pandemic IgG IgG antibody IgG response IgM/IgG Impact Limited Mild Moderate COVID-19 moderate disease Mortality mortality rate multivariable analysis negativity onset of symptoms Patient Predictive Prognosis progressed progression reported response risk factor SARS-CoV-2 SARS-CoV-2 antibody Seroconversion Spread Symptom the patient the SARS-CoV-2 treatment regimen univariable analysis was determined was performed Wuhan
[DOI] 10.3389/fimmu.2021.580147 PMC 바로가기 [Article Type] Immunology